MarketCap
Facebook
X
TelegramSeneca Biopharma, Inc. P/CF Ratio 2011-2026 | SNCA
Annual P/CF Ratio Seneca Biopharma, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| -0.0597 | -0.0586 | -0.138 | -0.297 | -0.261 | -0.616 | -3.67 | -3.51 | -1.41 | -0.939 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -0.0586 | -3.67 | -1.1 |
P/CF Ratio of other stocks in the Biotechnology industry
| Issuer | P/CF Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
FSD Pharma
HUGE
|
-1.79 | - | 5743.5 % | $ 69.7 M |  Canada |
 |
MorphoSys AG
MOR
|
-0.654 | - | 2.43 % | $ 254 M |  Germany |
 |
Happiness Biotech Group Limited
HAPP
|
-0.848 | - | 1.35 % | $ 17.8 M |  China |
 |
AgeX Therapeutics
AGE
|
-11.8 | - | -10.17 % | $ 12.2 K |  USA |
 |
I-Mab
IMAB
|
-0.266 | - | - | $ 866 M | China |
 |
Deciphera Pharmaceuticals
DCPH
|
-8.18 | - | - | $ 2.18 B | USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
11.6 | - | - | $ 40.3 B | USA |
 |
Genfit SA
GNFT
|
1.68 K | - | 2.54 % | $ 160 B |  France |
 |
Biophytis SA
BPTS
|
-13.9 | - | -13.47 % | $ 169 M | France |
 |
Alpine Immune Sciences
ALPN
|
-6.14 | - | - | $ 2.17 B | USA |
 |
ASLAN Pharmaceuticals Limited
ASLN
|
-28.3 | - | -14.27 % | $ 1.7 M |  Singapore |
 |
AstraZeneca PLC
AZN
|
9.7 | - | - | $ 96.9 B |  Britain |
 |
CureVac N.V.
CVAC
|
-4.82 | - | - | $ 867 M | Germany |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.88 | - | -1.52 % | $ 24.7 M | USA |
 |
Athira Pharma
ATHA
|
-0.0166 | - | - | $ 269 M | USA |
 |
Coherus BioSciences
CHRS
|
-1.63 | $ 1.38 | -3.17 % | $ 162 M | USA |
 |
BiondVax Pharmaceuticals Ltd.
BVXV
|
-30.2 | - | 0.74 % | $ 768 M |  Israel |
 |
Abcam plc
ABCM
|
172 | - | - | $ 4.9 B | Britain |
 |
Galera Therapeutics
GRTX
|
-0.63 | - | -32.59 % | $ 7.61 M | USA |
 |
Midatech Pharma plc
MTP
|
-117 | - | -18.52 % | $ 27.3 M | Britain |
 |
Affimed N.V.
AFMD
|
-6.09 | - | -34.95 % | $ 21.5 M | Germany |
 |
CRISPR Therapeutics AG
CRSP
|
-12.7 | $ 50.22 | -2.45 % | $ 4.52 B |  Schweiz |
 |
Институт стволовых клеток человека
ISKJ
|
-89 | - | - | - |  Russia |
 |
Checkmate Pharmaceuticals
CMPI
|
-0.982 | - | - | $ 231 M | USA |
 |
Celyad Oncology SA
CYAD
|
-0.379 | - | - | $ 12.5 M |  Belgium |
 |
Berkeley Lights
BLI
|
-2.46 | - | -7.31 % | $ 87 M | USA |
 |
Celldex Therapeutics
CLDX
|
-9.67 | $ 29.5 | -0.34 % | $ 1.96 B | USA |
 |
Generation Bio Co.
GBIO
|
-3.39 | - | - | $ 344 M | USA |
 |
IMV
IMV
|
-0.195 | - | - | $ 13.1 M | Canada |
 |
Akero Therapeutics
AKRO
|
-14.1 | - | - | $ 3.67 B | USA |
 |
Akouos
AKUS
|
-2.88 | - | 0.23 % | $ 488 M | USA |
 |
Ayala Pharmaceuticals
AYLA
|
-0.224 | - | - | $ 7.46 M | Israel |
|
Enlivex Therapeutics Ltd.
ENLV
|
-4.21 | $ 0.7 | 0.91 % | $ 32 M | Israel |
 |
Esperion Therapeutics
ESPR
|
-42.9 | $ 3.15 | 0.32 % | $ 655 M | USA |
 |
Cyclacel Pharmaceuticals
CYCCP
|
-0.0137 | - | -4.36 % | $ 27 M | USA |
 |
Eton Pharmaceuticals
ETON
|
53.1 | $ 31.66 | 3.7 % | $ 852 M | USA |
 |
Freeline Therapeutics Holdings plc
FRLN
|
-3.33 | - | - | $ 384 M | Britain |
 |
Gracell Biotechnologies
GRCL
|
-6.52 | - | - | $ 3.37 B | China |
 |
Exelixis
EXEL
|
13.2 | $ 53.51 | 0.98 % | $ 14.5 B | USA |
 |
Anika Therapeutics
ANIK
|
19.1 | $ 14.94 | 2.54 % | $ 214 M | USA |
 |
Advaxis
ADXS
|
-0.0633 | - | -9.65 % | $ 45.9 M | USA |
|
Forte Biosciences
FBRX
|
-6.59 | $ 17.03 | 0.18 % | $ 221 M | USA |
 |
Aeterna Zentaris
AEZS
|
-1.01 | - | 5.93 % | $ 314 M | Canada |
 |
Aeglea BioTherapeutics
AGLE
|
-4.6 | - | - | $ 1.01 B | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
-0.205 | - | - | $ 26.5 M | USA |
 |
AIkido Pharma
AIKI
|
-1.17 | - | 1.93 % | $ 17.4 M | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
-0.537 | $ 2.97 | 0.38 % | $ 4.89 M | Israel |
 |
Aptose Biosciences
APTO
|
-0.0645 | - | -45.71 % | $ 1.2 M | Canada |
 |
Aptinyx
APTX
|
-0.159 | - | -39.0 % | $ 4.57 M | USA |
 |
Albireo Pharma
ALBO
|
-5.09 | - | -0.23 % | $ 916 M | USA |